Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

HLA-B27 (B27) is strongly associated with spondyloarthopathy. The classical role of B27 is to present peptides from intracellular pathogens as a heterotrimeric complex with beta2 microglobulin for recognition by the T-cell receptor (TCR) of CD8 T-cells. In addition to heterotrimers, B27 can also be expressed as cell surface beta2-microglobulin (beta2m)-free homodimers (B27(2)). In addition to the TCR, MHC class I molecules bind to immunoregulatory receptors including members of the killer immunoglobulin-like receptor (KIR) and leukocyte immunoglobulin-like receptor (LILR) families. Rodents express the paired immunoglobulin receptor (PIR) family which are related to LILR. B27(2) but not beta2m-associated B27 binds to KIR3DL2 and rodent PIR. NK and T-cells expressing the immune receptor KIR3DL2, which interacts with B27(2), are expanded in B27 AS patients. Ligation of immune receptors by B27(2) promotes the survival of KIR-expressing leukocytes and modulates immune cytokine production. Upregulation ofB272 in spondyloarthritis and differential interaction of beta2m-associated HLA-B27 and B27(2) with immune receptors could be involved in the pathogenesis of B27-associated spondyloarthritis (AS).

Original publication

DOI

10.1007/978-1-4419-0298-6_21

Type

Journal article

Journal

Adv exp med biol

Publication Date

2009

Volume

649

Pages

277 - 285

Keywords

Dimerization, HLA-B27 Antigen, Humans, Killer Cells, Natural, Leukocytes, Protein Conformation, Receptors, Immunologic, Spondylarthritis, T-Lymphocytes